Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002006495-26-000008
Filing Date
2026-01-09
Accepted
2026-01-09 19:18:55
Documents
2
Period of Report
2026-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1768004332.html 3  
1 FORM 3 wk-form3_1768004332.xml 3 15430
2 EX-24.POA poafilehallett.txt EX-24.POA 3778
  Complete submission text file 0002006495-26-000008.txt   20791
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O EXSCIENTIA PLC, THE SCHRODINGER BLD, OXFORD SCIENCE PARK OXFORD X0 OX4 4GE
Business Address
Hallett David (Reporting) CIK: 0002006495 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40323 | Film No.: 26524366